Listen "Robert Lufkin MD: Extending Life with Rapamycin"
Episode Synopsis
For this weeks episode we are going to look at a brief interview I recently did with James Strole about my upcoming presentation at the RAADFEST conference in October in San Diego. While the interview is entitled ‘Extending Life with Rapamycin’, I want to be clear that 1- the use of rapamycin is an off label use of an FDA approved prescription only drug, 2-rapamycin is a potentially dangerous drug that should only be used under the care of a physician with experience in this area, and 3- although extremely promising longevity results are present in animal models the longevity benefits of rapamycin in humans are still being determined. As you can tell I am looking forward all the great speakers at the RAADFEST conference this fall. If are planning on attending please use code ‘LUFKIN’ at checkout for 10% off any registration. https://raadfest.com/Lies I Taught In Medical School : Free sample chapter- https://www.robertlufkinmd.com/lies/Complete Metabolic Heart Scan (LUFKIN20 for 20% off) https://www.innerscopic.com/Fasting Mimicking Diet (20% off) https://prolonlife.com/Lufkin At home blood testing (20% off) https://siphoxhealth.com/lufkin Web: https://robertlufkinmd.com/X: https://x.com/robertlufkinmdYoutube: https://www.youtube.com/robertLufkinmdSubstack: https://robertlufkinmd.substack.com Instagram: https://www.instagram.com/robertlufkinmd/LinkedIn: https://www.linkedin.com/in/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinThreads: https://www.threads.net/@robertlufkinmdFacebook: ...
More episodes of the podcast Health Longevity Secrets
Are Mitochondria The Real Secret to Aging?
23/12/2025
How to Avoid a Fatal Fracture
16/12/2025
What Is Next After the Apple Watch?
09/12/2025
The Cookbook That Saved My Life
02/12/2025
How to Survive The Holiday Air Travel
25/11/2025
What If Sugar Wasn't Sweet?
18/11/2025
Keto for Cancer?
11/11/2025
A Facelift Without A Scar?
28/10/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.